BMJ  1991;303:276-282 (3 August), doi:10.1136/bmj.303.6797.276

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.

Medical Research Council and Imperial Cancer Research Fund, Nuffield Department of Clinical Medicine, University of Oxford, Radcliffe Infirmary.

OBJECTIVE--To examine the relation between serum cholesterol concentration and mortality (from coronary heart disease and from other causes) below the range of cholesterol values generally seen in Western populations. DESIGN--Prospective observational study based on 8-13 years of follow up of subjects in a population with low cholesterol concentrations. SETTING--Urban Shanghai, China. SUBJECTS--9021 Chinese men and women aged 35-64 at baseline. MAIN OUTCOME MEASURE--Death from coronary heart disease and other causes. RESULTS--The average serum cholesterol concentration was 4.2 mmol/l at baseline examination, and only 43 (7%) of the deaths that occurred during 8-13 years of follow up were attributed to coronary heart disease. There was a strongly positive, and apparently independent, relation between serum cholesterol concentration and death from coronary heart disease (z = 3.47, p less than 0.001), and within the range of usual serum cholesterol concentration studied (3.8-4.7 mmol/l) there was no evidence of any threshold. After appropriate adjustment for the regression dilution bias, a 4 (SD 1)% difference in usual cholesterol concentration was associated with a 21 (SD 6)% (95% confidence interval 9% to 35%) difference in mortality from coronary heart disease. There was no significant relation between serum cholesterol concentration and death from stroke or all types of cancer. The 79 deaths due to liver cancer or other chronic liver disease were inversely related to cholesterol concentration at baseline. CONCLUSION--Blood cholesterol concentration was directly related to mortality from coronary heart disease even in those with what was, by Western standards, a "low" cholesterol concentration. There was no good evidence of an adverse effect of cholesterol on other causes of death.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Article

Low cholesterol and coronary heart disease.

T H Leigh
BMJ 1991 303: 993-994. [PDF]

This article has been cited by other articles:

• Kamari, Y., Bitzur, R., Cohen, H., Shaish, A., Harats, D. (2009). Should All Diabetic Patients Be Treated With a Statin?. Diabetes Care 32: S378-S383 [Full text]  
• Hennekens, C. H., Schneider, W. R., Barice, E. J., Hebert, P. R. (2009). Modest Dietary Reductions in Blood Cholesterol Have Important Public Health Benefits. J CARDIOVASC PHARMACOL THER 14: 85-88 [Abstract]  
• Rosengren, A., Perk, J., Dallongeville, J. (2009). CHAPTER 12 Prevention of Cardiovascular Disease. ESC Textbook of Cardiovascular Medicine 2: med-9780199566990-chapter-med-9780199566990-chapter [Abstract] [Full text]  
• Chen, R., Hu, Z., Wei, L., Qin, X., McCracken, C., Copeland, J. R. (2008). Severity of depression and risk for subsequent dementia: cohort studies in China and the UK. Br. J. Psychiatry 193: 373-377 [Abstract] [Full text]  
• Bhatnagar, D., Soran, H., Durrington, P. N (2008). Hypercholesterolaemia and its management. BMJ 337: a993-a993 [Full text]  
• Levine, A. P., Mikhailidis, D. P., Moross, T., Benson, K., Gor, M. (2008). Achieving Vascular Risk Factor Targets: A Survey of a London General Practice. ANGIOLOGY 59: 36-46 [Abstract]  
• Josan, K. MD, Majumdar, S. R. MD MPH, McAlister, F. A. MD MSc (2008). The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. CMAJ 178: 576-584 [Abstract] [Full text]  
• Gotto, A. M. Jr (2008). The Cholesterol Wars: The Cholesterol Skeptics vs the Preponderance of Evidence. Circulation 117: e163-e164 [Full text]  
• Sritara, P., Patoomanunt, P., Woodward, M., Narksawat, K., Tulyadachanon, S., Ratanachaiwong, W., Sritara, C., Barzi, F., Yamwong, S., Tanomsup, S. (2008). Associations Between Serum Lipids and Causes of Mortality in a Cohort of 3499 Urban Thais: The Electricity Generating Authority of Thailand (EGAT) Study. ANGIOLOGY 58: 757-763 [Abstract]  
• Jha, P. MD DPhil, Chen, Z. MD DPhil (2007). Poverty and chronic diseases in Asia: challenges and opportunities. CMAJ 177: 1059-1062 [Full text]  
• Domanski, M. J. (2007). Primary Prevention of Coronary Artery Disease. NEJM 357: 1543-1545 [Full text]  
• Razak, F., Anand, S. S., Shannon, H., Vuksan, V., Davis, B., Jacobs, R., Teo, K. K., McQueen, M., Yusuf, S., for the SHARE Investigators, (2007). Defining Obesity Cut Points in a Multiethnic Population. Circulation 115: 2111-2118 [Abstract] [Full text]  
• Steinberg, D. (2006). Thematic review series: The Pathogenesis of Atherosclerosis. An interpretive history of the cholesterol controversy, part V: The discovery of the statins and the end of the controversy. J. Lipid Res. 47: 1339-1351 [Abstract] [Full text]  
• Costa, J., Borges, M., David, C., Vaz Carneiro, A. (2006). Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials. BMJ 332: 1115-1124 [Abstract] [Full text]  
• Cohen, J. C., Boerwinkle, E., Mosley, T. H. Jr., Hobbs, H. H. (2006). Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.. NEJM 354: 1264-1272 [Abstract] [Full text]  
• Chen, Z., Lee, L., Chen, J., Collins, R., Wu, F., Guo, Y., Linksted, P., Peto, R. (2005). Cohort Profile: The Kadoorie Study of Chronic Disease in China (KSCDC). Int J Epidemiol 34: 1243-1249 [Full text]  
• Ebrahim, S., Smeeth, L. (2005). Non-communicable diseases in low and middle-income countries: a priority or a distraction?. Int J Epidemiol 34: 961-966 [Full text]  
• Collins, P, Brittenden, J (2004). Masterclass series in peripheral arterial disease: Lipid-lowering therapy in patients with peripheral arterial disease. Vasc Med 9: 303-306  
• Tunon, J., Blanco-Colio, L. M., Martin-Ventura, J. L., Egido, J. (2004). Intensive treatment with statins and the progression of cardiovascular diseases: the beginning of a new era?. Nephrol Dial Transplant 19: 2696-2699 [Full text]  
• Critchley, J., Liu, J., Zhao, D., Wei, W., Capewell, S. (2004). Explaining the Increase in Coronary Heart Disease Mortality in Beijing Between 1984 and 1999. Circulation 110: 1236-1244 [Abstract] [Full text]  
• He, J., Gu, D., Reynolds, K., Wu, X., Muntner, P., Zhao, J., Chen, J., Liu, D., Mo, J., Whelton, P. K., for the InterASIA Collaborative Group, (2004). Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China. Circulation 110: 405-411 [Abstract] [Full text]  
• Forrester, J. S., Bairey-Merz, C. N., Kaul, S. (2000). The aggressive low density lipoprotein lowering controversy. J Am Coll Cardiol 36: 1419-1425 [Abstract] [Full text]  
• Cockcroft, J.R., Wilkinson, I.B. (2000). Cholesterol reduction, statins and the cytochrome P-450 system. Eur Heart J 21: 1555-1556  
• Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, A. M. Jr, for the AFCAPS/TexCAPS Research Group, (1998). Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels: Results of AFCAPS/TexCAPS. JAMA 279: 1615-1622 [Abstract] [Full text]  
• Zheng-Ming, C., Xu, Z., Collins, R., Li, W.-X., Peto, R. (1997). Early Health Effects of the Emerging Tobacco Epidemic in China: A 16-Year Prospective Study. JAMA 278: 1500-1504 [Abstract]  
• Prisco, D., Caciolli, S., Del Pace, S., Gensini, G. F. (1996). State-of-the-Art Review : Sex and Cardiovascular Risk Factors. CLIN APPL THROMB HEMOST 2: 94-102  
• Verschuren, W. M. M., Jacobs, D. R., Bloemberg, B. P. M., Kromhout, D., Menotti, A., Aravanis, C., Blackburn, H., Buzina, R., Dontas, A. S., Fidanza, F., Karvonen, M. J., Nedelijkovic, S., Nissinen, A., Toshima, H. (1995). Serum Total Cholesterol and Long-term Coronary Heart Disease Mortality in Different Cultures: Twenty-five--Year Follow-up of the Seven Countries Study. JAMA 274: 131-136 [Abstract]  
• Iribarren, C., Reed, D. M., Wergowske, G., Burchfiel, C. M., Dwyer, J. H. (1995). Serum Cholesterol Level and Mortality Due to Suicide and Trauma in the Honolulu Heart Program. Arch Intern Med 155: 695-700 [Abstract]  
• Newman, T. B., Garber, A. M., Holtzman, N. A., Hulley, S. B. (1995). Problems With the Report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Arch Pediatr Adolesc Med 149: 241-247 [Abstract]  
• Garg, A., Bantle, J. P., Henry, R. R., Coulston, A. M., Griver, K. A., Raatz, S. K., Brinkley, L., Chen, Y-D. I., Grundy, S. M., Huet, B. A., Reaven, G. M. (1994). Effects of Varying Carbohydrate Content of Diet in Patients With Non--Insulin-Dependent Diabetes Mellitus. JAMA 271: 1421-1428 [Abstract]  
• Naylor, C. D. (1993). Cholesterol Testing in Young Adults: Prudent or Profligate?. JAMA 269: 1426-1427 [Abstract]  
• Neaton, J. D., Blackburn, H., Jacobs, D., Kuller, L., Lee, D.-J., Sherwin, R., Shih, J., Stamler, J., Wentworth, D. (1992). Serum Cholesterol Level and Mortality Findings for Men Screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 152: 1490-1500 [Abstract]  
• Smith, G. D., Shipley, M. J., Marmot, M. G., Rose, G. (1992). Plasma Cholesterol Concentration and Mortality: The Whitehall Study. JAMA 267: 70-76 [Abstract]  

Online poll

Find out more here>> and here>>